Merck KGaA CEO Sees 'Zero' Chance of Selling Liquid Crystals Business

The transcript discusses global economic concerns like China's slowdown, Brexit, and Germany's economic issues, and their impact on businesses. Merck is optimistic about its healthcare and life science sectors, driven by innovation and research. The company emphasizes its structure as a science and technology firm rather than a conglomerate, highlighting synergies between its divisions. Merck acknowledges risks such as healthcare reform and geopolitical factors but remains confident in its growth strategy. The company plans to focus on healthcare innovation, performance materials, and semiconductors for future growth.

In what ways does the speaker believe their conglomerate structure benefits their company?

What role do semiconductors play in the future growth of the company according to the speaker?